The Record header image

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

May 2024

Requirements and codes changed for some medical benefit drugs

Blue Cross Blue Shield of Michigan and Blue Care Network encourage proper utilization of high-cost medications that are covered under the medical benefit. As part of this effort, we maintain comprehensive lists of requirements for our members.

In January, February and March 2024, we added requirements for some medical benefit drugs. These requirements went into effect on various dates. In addition, some drugs were assigned new HCPCS codes.

Changes in requirements

For Blue Cross commercial and BCN commercial members, we added prior authorization requirements, site-of-care requirements or both for the following drugs:

HCPCS code

Brand name

Generic name

Requirement

Prior authorization

Site of care

J1599

Alyglo™

Immune globulin intravenous, human-stwk 10%

J3590**

Amtagvi™

Lifileucel

 

J3590**

Avzivi®

Bevacizumab-tnjn

 

J3590**

Ryzneuta®

Efbemalenograstim alfa-vuxw

 

For Medicare Plus Blue℠ and BCN Advantage℠ members, we added prior authorization requirements for the following drugs:

HCPCS code

Brand name

Generic name

For dates of service on or after

J3590

Casgevy™

Exagamglogene autotemcel

Jan. 2, 2024

J3590

Lyfgenia™

Lovotibeglogene autotemcel

Jan. 2, 2024

J3490

Omisirge®

Omidubicel-onlv

Feb. 1, 2024

J3590

Bimzelx®

Bimekizumab-bkzx

Feb. 12, 2024

J3590

Cosentyx® IV

Secukinumab

Feb. 12, 2024

J3590

Omvoh™ IV

Mirikizumab-mrkz

Feb. 12, 2024

J3590

Pombiliti™

Cipaglucosidase alfa-atga

Feb. 12, 2024

J3490

Rivfloza™

Nedosiran

Feb. 12, 2024

J3490

Zilbrysq®

Zilucoplan

Feb. 12, 2024

J3590

Zymfentra™ SC

Infliximab-dyyb

Feb. 12, 2024

J3590

Adzynma

ADAMTS13, recombinant-krhn

March 1, 2024

J3490

Wainua™

Eplontersen

March 1, 2024

Code changes

The table below shows HCPCS code changes that were effective January 2024 for the medical benefit drugs managed by Blue Cross and BCN.

New HCPCS code

Brand name

Generic name

J0217

Lamzede®

Velmanase alfa

J1304

Qalsody®

Tofersen

J1412

Roctavian™

Valoctocogene roxaparvovec-rvox

J1413

Elevidys

Delandistrogene moxeparvovec-rokl

J2508

Elfabrio®

Pegunigalsidase alfa-iwxj

J3401

Vyjuvek®

Beremagene geperpavec-svdt

J9333

Rystiggo®

Rozanolixizumab-noli

J9334

Vyvgart® Hytrulo

Efgartigimod alfa and hyaluronidase-qvfc

Drug lists

For additional details, see the following drug lists:

These lists are also available on the following pages of the ereferrals.bcbsm.com website:

Additional information about these requirements

We communicated these changes previously through provider alerts, which contain additional details.

You can view the provider alerts on ereferrals.bcbsm.com and on our Provider Resources site, which is accessible through our provider portal, availity.com.***

Additional information for Blue Cross commercial groups

For Blue Cross commercial groups, authorization requirements apply only to groups that participate in the standard commercial Medical Drug Prior Authorization Program for drugs administered under the medical benefit. To determine whether a group participates in the prior authorization program, see the Specialty Pharmacy Prior Authorization Master Opt-in/out Group List. A link to this list is also available on the Blue Cross Medical Benefit Drugs page of the ereferrals.bcbsm.com website.

Blue Cross and Blue Shield Federal Employee Program® members and UAW Retiree Medical Benefits Trust (non-Medicare) members don't participate in the standard prior authorization program.

Reminder

An authorization approval isn’t a guarantee of payment. Health care providers need to verify eligibility and benefits for members.

**May be assigned a unique code in the future.

***Blue Cross Blue Shield of Michigan and Blue Care Network don’t own or control this website.

Availity® is an independent company that contracts with Blue Cross Blue Shield of Michigan and Blue Care Network to offer provider portal and electronic data interchange services.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2023 American Medical Association. All rights reserved.